Literature DB >> 18059485

In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML.

A Liso, A Bogliolo, V Freschi, M P Martelli, S A Pileri, M Santodirocco, N Bolli, M F Martelli, B Falini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18059485     DOI： 10.1038/sj.leu.2405045

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

Review 1.  Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.

Authors:  Rachel Rau; Patrick Brown
Journal:  Hematol Oncol       Date:  2009-12       Impact factor: 5.271

2.  A novel mechanism of NPM1 cytoplasmic localization in acute myeloid leukemia: the recurrent gene fusion NPM1-HAUS1.

Authors:  Paulo Vidal Campregher; Welbert de Oliveira Pereira; Bianca Lisboa; Renato Puga; Elvira Rodrigues Pereira Velloso Deolinda; Ricardo Helman; Luciana Cavalheiro Marti; João Carlos Campos Guerra; Kalliopi N Manola; Roberta Cardoso Petroni; Alanna Mara Pinheiro Sobreira Bezerra; Fernando Ferreira Costa; Nelson Hamerschlak; Fábio Pires de Souza Santos
Journal:  Haematologica       Date:  2016-04-01       Impact factor: 9.941

3.  Oridonin induces NPM mutant protein translocation and apoptosis in NPM1c+ acute myeloid leukemia cells in vitro.

Authors:  Fei-Fei Li; Sha Yi; Lu Wen; Jing He; Li-Jing Yang; Jie Zhao; Ben-Ping Zhang; Guo-Hui Cui; Yan Chen
Journal:  Acta Pharmacol Sin       Date:  2014-06       Impact factor: 6.150

4.  Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish.

Authors:  Niccolò Bolli; Elspeth M Payne; Clemens Grabher; Jeong-Soo Lee; Adam B Johnston; Brunangelo Falini; John P Kanki; A Thomas Look
Journal:  Blood       Date:  2010-03-02       Impact factor: 22.113

Review 5.  Biological and clinical consequences of NPM1 mutations in AML.

Authors:  E M Heath; S M Chan; M D Minden; T Murphy; L I Shlush; A D Schimmer
Journal:  Leukemia       Date:  2017-01-23       Impact factor: 11.528

Review 6.  Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia.

Authors:  Margaret L Gulley; Thomas C Shea; Yuri Fedoriw
Journal:  J Mol Diagn       Date:  2009-12-03       Impact factor: 5.568

Review 7.  Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications.

Authors:  P Sportoletti; E Varasano; R Rossi; A Mupo; E Tiacci; G Vassiliou; M P Martelli; B Falini
Journal:  Leukemia       Date:  2014-09-02       Impact factor: 11.528

8.  Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm.

Authors:  Fabio Facchetti; Stefano A Pileri; Claudio Agostinelli; Maria Paola Martelli; Marco Paulli; Adriano Venditti; Massimo F Martelli; Brunangelo Falini
Journal:  Haematologica       Date:  2008-12-09       Impact factor: 9.941

9.  Monoclonal antibodies against nucleophosmin mutants: potentials for the detection of acute myeloid leukemia.

Authors:  Shi Tan; Ling Zhang; Xiao-Ming Zhong; Zai-Lin Yang; Liu-Yang Zhao; Yu-Jie Gao; Hui-Yuan Shao; Feng-Xian Qin; Xian-Chun Chen; Hui-Juan Zhang; Hui Chen; Li Wang
Journal:  Int J Med Sci       Date:  2011-05-17       Impact factor: 3.738

10.  Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia.

Authors:  Kateřina Kuželová; Barbora Brodská; Ota Fuchs; Marie Dobrovolná; Petr Soukup; Petr Cetkovský
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.